Brand Description
VOYXACT is a newly FDA-approved medication indicated for reducing proteinuria in adults with primary immunoglobulin A nephropathy (IgAN), representing the first and only APRIL blocker for this condition.
Associated Domains
IAB Categories:
Health & Fitness
IAB Ad Products:
Health and Medical ServicesPharmaceuticals
| ID | Domain | Seat | Bid | Timestamp | Status | Ad Format | Sub Format | Size | Quality Score | Data Transferred | Computational Cost |
|---|